packageIpilimumab

ipilimumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ipilimumab is a monoclonal antibody used to treat several cancers, including melanoma, renal cell carcinoma, non-small-cell lung cancer, mesothelioma, and colorectal cancer. It is approved and authorised in the European Union, where it is used in the treatment of these cancers.

Summary written by glm-5.3-flash from Wikidata Q2459042 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ipilimumab
ATC codes:L01FX04
DrugBank:DB06186
Wikidata:Q2459042
molar mass:148000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown